PCVX · Vaxcyte, Inc.
Market Cap
$9.10B
Shares
148.81M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-05 | — | |
| 10-Q | 2026-08-05 | 2026-06-30 | |
| 8-K | 2026-07-15 | 2026-07-13 | |
| 8-K | 2026-06-23 | 2026-06-17 | |
| 8-K | 2026-06-16 | 2026-06-15 | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| 8-K | 2026-05-06 | — | |
| DEF 14A | 2026-04-23 | 2026-06-15 | |
| 8-K | 2026-02-24 | — | |
| 10-K | 2026-02-24 | 2025-12-31 | |
| 8-K | 2026-02-24 | — | |
| 8-K | 2026-02-02 | 2026-01-29 | |
| 8-K | 2025-12-19 | 2025-12-18 | |
| 8-K | 2025-11-04 | — | |
| 10-Q | 2025-11-04 | 2025-09-30 | |
| 8-K | 2025-09-30 | 2025-09-24 | |
| 8-K | 2025-08-06 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-06-17 | 2025-06-12 | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| 8-K | 2025-05-07 | — | |
| 8-K | 2025-05-01 | — | |
| DEF 14A | 2025-04-28 | 2025-06-12 | |
| 8-K | 2025-03-31 | — | |
| 8-K | 2025-02-25 | — | |
| 10-K | 2025-02-25 | 2024-12-31 | |
| 8-K | 2024-11-21 | 2024-11-15 | |
| 8-K | 2024-11-05 | — | |
| 10-Q | 2024-11-05 | 2024-09-30 | |
| 8-K | 2024-09-06 | 2024-09-04 | |
| 8-K | 2024-09-03 | — | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-08-06 | — | |
| 8-K | 2024-07-02 | 2024-06-27 | |
| 8-K | 2024-06-10 | 2024-06-06 | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 8-K | 2024-05-08 | — | |
| DEF 14A | 2024-04-15 | 2024-06-06 | |
| 10-K | 2024-02-27 | 2023-12-31 | |
| 8-K | 2024-02-27 | — | |
| 8-K | 2024-01-31 | 2024-01-30 | |
| 8-K | 2023-11-28 | 2023-11-27 | |
| 8-K | 2023-11-27 | 2023-11-21 | |
| 10-Q | 2023-11-06 | 2023-09-30 | |
| 8-K | 2023-11-06 | — | |
| 8-K | 2023-10-16 | 2023-10-13 | |
| 8-K | 2023-10-04 | 2023-09-28 | |
| 8-K | 2023-09-07 | 2023-09-01 | |
| 8-K | 2023-08-08 | — | |
| 10-Q | 2023-08-08 | 2023-06-30 |
Showing 1–50 of 96 filings
Key facts
CIK
1649094
CUSIP
92243G108
13F (30d)
285 filings
284 filers
Visit website
Investor relations